Who’s Going to ASGCT 2027
May 3–7, 2027 Philadelphia, PA ~8k attendees Website
120 exhibitors at the American Society of Gene & Cell Therapy (ASGCT) 30th Annual Meeting, an ~8,000-person, mostly biopharma meeting of gene and cell therapy researchers. As of Oct 29, 2026.
Speakers and other attendees will be added as ASGCT 2027 gets closer.
| Organization | ASGCT 2027 Attendance |
|---|---|
AAVnerGene Rockville, MD | |
AAV specialist offering vector design, packaging, capsid libraries and engineered capsids, characterization services, and catalog AAV plasmids, viruses and reagents. | Booth Exhibiting at Booth 1112 |
Admera Health South Plainfield, NJ | |
Genomics and multi-omics service lab offering RNA, single-cell, spatial, whole-genome and epigenetic sequencing with bioinformatics for researchers and drug developers. | Booth Exhibiting at Booth 907 |
AGC Biologics Bothell, WA | |
Contract developer and manufacturer of protein biologics, cell and gene therapies and mRNA, with GMP sites across three continents. | Booth Exhibiting at Booth 707 |
Altasciences Laval, QC, Canada | |
Drug development CRO running preclinical safety and clinical pharmacology studies, with bioanalysis, formulation, manufacturing and data services. | Booth Exhibiting at Booth 500 |
Andelyn Biosciences Columbus, OH | |
Viral vector CDMO for gene therapy, covering plasmid engineering, process and analytical development, and clinical and commercial GMP production of AAV and other vectors. | Booth Exhibiting at Booth 237 |
Ansa Biotechnologies Emeryville, CA | |
Makes synthetic DNA with an enzymatic synthesis platform, supplying clonal plasmids and sequence-verified linear fragments, including complex sequences, under an on-time delivery guarantee. | Booth Exhibiting at Booth 945 |
Makes GMP-grade nucleases for bioprocessing that strip residual DNA during viral vector manufacturing, working at high-salt or physiological salt conditions. | Booth Exhibiting at Booth 1143 |
Sells AI-guided genetic design and stable producer cell line platforms for lentivirus and AAV, plus mRNA expression optimization, to biologics and genetic medicine developers. | Booth Exhibiting at Booth 1127 |
Gene therapy developer and Bayer subsidiary building AAV treatments for Parkinson's disease, heart failure and other rare and common conditions. | Booth Exhibiting at Booth 422 |
Avance Biosciences Houston, TX | |
Analytical and bioanalytical testing lab for cell and gene therapies: potency assays, biodistribution, immunogenicity, cell bank characterization and NGS safety testing. | Booth Exhibiting at Booth 504 |
Axolabs Kulmbach, Germany | |
Contract research and manufacturing partner for oligonucleotide and other nucleic acid therapeutics, from discovery through clinical and commercial supply, with German and US sites. | Booth Exhibiting at Booth 1506 |
Bio-Rad Hercules, CA | |
Makes droplet digital PCR and other instruments and reagents for measuring viral titer, vector purity, copy number and cell phenotype in cell and gene therapy. | Booth Exhibiting at Booth 815 |
Supplies GMP cytokines and growth factors, antibodies, small molecules and analytical instruments through brands including R&D Systems, Tocris, Novus Biologicals and ProteinSimple. | Booth Exhibiting at Booth 1201 |
Bioanalytical lab providing pharmacokinetic, immunogenicity, biomarker and CMC testing under GxP for drug developers, with sites in the US, Australia and Germany. | Booth Exhibiting at Booth 805 |
Biocytogen Waltham, MA | |
Preclinical CRO offering off-the-shelf humanized and gene-edited mouse models, custom model generation, efficacy and pharmacology studies, and fully human antibody discovery. | Booth Exhibiting at Booth 502 |
Boreal Biomanufacturing Ottawa, ON, Canada | |
The Ottawa Hospital's not-for-profit manufacturing centre, formerly its Biotherapeutics Manufacturing Centre, making viral vector, cell therapy and oncolytic virus products for early-phase trials. | Booth Exhibiting at Booth 223 |
BPS Bioscience San Diego, CA | |
Makes recombinant proteins, assay kits, engineered cell lines and ready-to-use lentiviruses for drug discovery research. | Booth Exhibiting at Booth 1542 |
c-LEcta Leipzig, Germany | |
Develops and produces engineered enzymes for food, feed and pharmaceutical uses, including nucleases for removing DNA in biologics and viral vector processing; part of Kerry. | Booth Exhibiting at Booth 1213 |
Catalent Bridgewater, NJ | |
Contract developer and manufacturer of AAV vectors and CAR-T cell therapies, with clinical and commercial production plus fill-finish and packaging in the US and Europe. | Booth Exhibiting at Booth 525 |
Cellares South San Francisco, CA | |
Cell therapy development and manufacturing provider that runs clinical and commercial production on its own automated, high-throughput manufacturing platform. | Booth Exhibiting at Booth 413 |
Find buyers from companies at ASGCT 2027
Tell us what you sell and we’ll find the people at these companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
When and where is ASGCT 2027?
ASGCT 30th Annual Meeting runs May 3–7, 2027, at the Pennsylvania Convention Center in Philadelphia, PA.
Where is the ASGCT 2027 floor plan?
See the organizer’s interactive exhibit hall floor plan. This guide gives each exhibitor’s booth number.
How do I register for ASGCT 2027?
Fees and registration are on the organizer's registration page.
What is ASGCT 2027?
The 30th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), held May 3–7, 2027 at the Pennsylvania Convention Center in Philadelphia. It is the largest yearly meeting of the gene and cell therapy field — nearly 8,000 people came in 2026, mostly from industry, with about one in three from academia — and its exhibit hall gathers the manufacturers, tool makers, service companies and therapy developers that serve them.
What is in this guide?
Every organization exhibiting at ASGCT 2027 so far: 120 exhibitors with their booth numbers from the public floor plan — 120 organizations in one list, each typed and tagged with up to three focus areas, and a short description for 120.
Where is the program?
ASGCT has not published its 2027 scientific program yet. It will appear on the meeting’s Program + Workshops page and in its interactive program planner, expected in spring 2027; this guide will add the organizations on it then. Today it lists who is exhibiting, from the public exhibit floor plan.
Where does this list come from?
The organizer’s own public exhibit floor plan and the profile each exhibitor published on it — address, website, product categories and a company description. 91 of the 120 exhibitor listings had published a description and 74 a list of product categories; where an exhibitor published none, the short description is condensed from its own website or states what is well established about it. Nothing here requires a login.
How are organizations typed?
By what each organization sells or does for gene and cell therapy: contract manufacturers, reagent and plasmid suppliers, instrument and bioprocess equipment makers, analytical and testing services, research CROs and other services, software and data — then the therapy developers themselves, and the societies, patient groups and research institutes. The focus tags (at most three each) are judged from each exhibitor’s own profile and website.
How current is it?
Pulled from the public floor plan on October 29, 2026. Exhibitors keep signing up until the meeting, so the list will grow.
Why are there no names?
This guide is about which organizations are in the room, not which people. It never publishes a person’s name.
Browse ASGCT 2027 by
Organizations with their own page
120 organizations — every exhibitor and every organization with 1 or more presentations.
- AAVnerGene
- Admera Health
- AGC Biologics
- AlpalifeBio
- Altasciences
- Andelyn Biosciences
- Ansa Biotechnologies
- ArcticZymes
- ASGCT
- Asimov
- AskBio
- Avance Biosciences
- Axolabs
- Bio-Rad
- Bio-Techne
- BioAgilytix
- Biocytogen
- Boreal Biomanufacturing
- BPS Bioscience
- c-LEcta
- Catalent
- Cellares
- CellBios
- Certest Biotec
- Countable Labs
- CPC Biotech
- Creative Biogene
- Curi Bio
- Cyagen
- Danaher Life Sciences
- DINAMIQS
- ElevateBio
- EMIT Imaging
- Eurofins BioPharma Product Testing
- ExCell Bio
- Forge Biologics
- Franklin Biolabs
- Fujifilm
- GEA
- GemPharmatech
- GeneMedi
- GENEWIZ (Azenta Life Sciences)
- Genezen
- GenScript
- GenScript ProBio
- Harro Höfliger
- Inotiv
- Isolere Bio
- ITR Laboratories
- JOINN-Biomere
- KACTUS
- KCAS Bio
- KROMATID
- Kuhner
- Lonza
- MACHEREY-NAGEL
- Mass General Brigham
- MaxCyte
- MedChemExpress
- MilliporeSigma
- Miltenyi Biotec
- Minaris
- Minerva Biolabs
- MingCeler
- Mission Bio
- Murata
- NanoFCM
- National Jewish Health
- New England Biolabs
- NOF
- Nona Biosciences
- Novogene
- OriGen Biomedical
- OXB
- Oxford Nanopore Technologies
- PackGene Biotech
- PamDx
- Pharmaron
- PhoenixBio
- Phosphorex
- PlasmidFactory
- Plasmidsaurus
- Polysciences
- Portal Biotechnologies
- PROGEN
- Promega
- Propria
- PsychoGenics
- Puresyn
- Repligen
- Samyang Biopharm
- Sartorius
- ScaleReady
- SHENTEK
- SK pharmteco
- SNBL
- Solvias
- STEMCELL Technologies
- Taiwan Cell Manufacturing
- Teknova
- Terumo Blood and Cell Technologies
- Touchlight
- Tozaro
- Ubigene
- uBriGene
- Unchained Labs
- USP
- Vaisala
- VectorBuilder
- Viralgen
- Virovek
- Virscio
- VisionGift
- VIVEbiotech
- VJ Bio
- Vyriad
- Waters
- WiCell
- Yecuris
- ZentriForce Pharma
Not affiliated with the American Society of Gene & Cell Therapy. Organization details are derived from ASGCT’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction